In 2021, Sly, biochemistry professor Harry Brumer, and a group of other researchers at the UBC developed GlycoCage, a ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

In patients with IBD on maintenance IFX, use of 5-ASA and immunomodulators does not significantly reduce flares, infections, or adverse reactions.

Black patients face higher complications related to inflammatory bowel disease than White patients, according to a study presented at DDW 2025.

Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease ...